Skip to main content Deutsch


Department of Health Economics (DHE)

Economic evaluation of the PAX-D study

Dates: 2019-2024
Funding: UK NIHR EME
Collaborator(s): Department of Psychiatry, University of Oxford
Information: Judit Simon (co-PI), Timea Helter, Agata Laszewska

The PAX-D study is a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. The DHE leads the main health economic analysis.